Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk.
about
The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomesDynamic changes in biomarkers in acute human immunodeficiency virus infections: a case report.Human Immunodeficiency Virus (HIV).A mathematical approach to estimate the efficacy of individual-donation and minipool nucleic acid amplification test options in preventing transmission risk by window period and occult hepatitis B virus infections.Sensitivity of individual-donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections.Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus.Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.A mathematical model for estimating residual transmission risk of occult hepatitis B virus infection with different blood safety scenarios.[Human immunodeficiency virus: position of Blood Working Group of the Federal Ministry of Health].Inclusion of human immunodeficiency virus Type 2 (HIV-2) in a multiplex transcription-mediated amplification assay does not affect detection of HIV-1 and hepatitis B and C virus genotypes: a multicenter performance evaluation study.Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios.
P2860
Q35251300-1C5ED946-04B7-4561-9ED0-673AE9FB319CQ36261775-B982BAD6-DDE6-44FA-81C2-02F35200C90EQ37045832-B5CA3550-6CA5-4A9C-B0DD-5E4E78254A4DQ37305718-F8DCE563-FA4E-4DBC-93F8-68ECD30DADDDQ37333836-8225759E-5E04-459F-85E1-9E3CA2CE3DFBQ37618604-BBFF7875-73A2-475B-94E5-8FF80BC041F0Q38984355-DDEFA8FD-593D-4CA2-89B1-AF8335EA34C9Q40314561-137CED72-5FF4-46B8-BEAA-A454C3956934Q40942917-2797D1AB-2483-4D6B-8946-B9D502DBDFACQ41647666-1A20D0FD-760C-4B8D-9A9C-A9C981F0F464Q42258338-EB374FB1-8ECC-4F13-B3EB-7DB5D3B030EC
P2860
Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of human immunodefi ...... cations for transmission risk.
@en
Comparison of human immunodefi ...... cations for transmission risk.
@nl
type
label
Comparison of human immunodefi ...... cations for transmission risk.
@en
Comparison of human immunodefi ...... cations for transmission risk.
@nl
prefLabel
Comparison of human immunodefi ...... cations for transmission risk.
@en
Comparison of human immunodefi ...... cations for transmission risk.
@nl
P2093
P2860
P356
P1433
P1476
Comparison of human immunodefi ...... cations for transmission risk.
@en
P2093
Charl Coleman
Harry van Drimmelen
Josephine Mitchel
Marion Vermeulen
Nico Lelie
Ravi Reddy
Tracy Fickett
P2860
P304
P356
10.1111/TRF.12117
P433
P577
2013-02-27T00:00:00Z